xIPOmeter
IntraBio
Gráfico NewsHeat
- Semana
- Mes
- Año
- Noticias de prensa
- Noticias corporativas
Los datos del gráfico anterior se basan en datos derivados de nuestro modelo de cálculo XP patentado y pueden modificarse, ajustarse y actualizarse sin previo aviso.
Valoración de empresas
- Valoración
- Precio de las acciones
- Financiación acumulada
Los datos de los cuadros y gráficos se basan en datos de fuentes públicas y, aunque hacemos todo lo posible por recopilarlos, es posible que no coincidan con los datos reales del emisor.
*** - Para ver los datos, conéctese a su cuenta o cree una nueva.
Noticias relacionadas con IntraBio7
IntraBioIntraBio Appoints Dr. Marc C. Patterson, US Chief Medical Officer ...
Dr. Patterson joins IntraBio after a distinguished career at the Mayo Clinic in Rochester, Minnesota, where he served as a Professor of Neurology, Pediatrics, ...
https://www.morningstar.com/news/accesswire/969758msn/intrabio-appoints-dr-marc-c-patterson-us-chief-medical-officerIntraBioIntraBio Appoints Dr. Marc C. Patterson, US Chief Medical Officer
AUSTIN, TX / ACCESS Newswire / January 17, 2025 / IntraBio Inc. proudly announces that Marc C. Patterson, MD, FRACP, FAAN, FANA, has joined the company as ...
https://finance.yahoo.com/news/intrabio-appoints-dr-marc-c-130000914.htmlIntraBioCurant Health Selected By IntraBio as the Exclusive Specialty ...
This groundbreaking therapy is the first FDA-approved stand-alone treatment for Niemann-Pick Disease Type C (NPC), a rare genetic disorder. ADVERTISEMENT....
https://finance.yahoo.com/news/curant-health-selected-intrabio-exclusive-133000400.htmlIntraBioUS FDA approves IntraBio's drug for rare genetic disease
(Reuters) -The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator said on Tuesday, ...
https://www.msn.com/en-us/health/other/us-fda-approves-intrabios-drug-for-rare-genetic-disease/ar-AA1r90QN?ocid=BingNewsVerpIntraBioIntraBio Announces U.S. FDA Approval of AQNEURSA for the ...
AUSTIN, Texas, September 25, 2024--IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative diseases, ...
https://finance.yahoo.com/news/intrabio-announces-u-fda-approval-120000760.html
Ver más (2)